Clinical Trial Detail

NCT ID NCT03403634
Title Celecoxib, Recombinant Interferon Alfa-2b, and Rintatolimod in Treating Patients With Colorectal Cancer Metastatic to the Liver
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Roswell Park Cancer Institute
Indications

colorectal cancer

Therapies

Celecoxib + Interferon alpha-2b + Rintatolimod

Age Groups: adult senior

No variant requirements are available.